BENOXAPROFEN, A POTENT INHIBITOR OF MONOCYTE/ENDOTHELIAL-CELL INTERACTION
- 15 September 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 324 (8403) , 643
- https://doi.org/10.1016/s0140-6736(84)90637-8
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- MODE OF ACTION OF BENOXAPROFENThe Lancet, 1984
- Benoxaprofen: A pro-oxidant anti-inflammatory drug?Inflammation Research, 1984
- Bradykinin-stimulated prostaglandin E2 production by endothelial cells and its modulation by antiinflammatory compoundsInflammation, 1981
- Two-step separation of human peripheral blood monocytes on discontinuous density gradients of colloidal silica-polyvinylpyrrolidinoneJournal of Immunological Methods, 1977
- The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesisJournal of Pharmacy and Pharmacology, 1977
- Effects of cytotoxic sera on endothelium in vitroNature, 1974